Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
TNXP Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
187.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-3.50%
TNXP Stock Analysis
TNXP
PE Ratio:
TNXP
PEG Ratio:
Not Available
TNXP
Forward EPS Growth (12 month):
0.00%
TNXP
PS Ratio:
10.4
TNXP
PSG Ratio:
0.1
TNXP
Forward Revenue Growth (12 month):
205.30%
TNXP Articles
No data was found